Introduction
Although the in vitro production of bovine embryos has been established since the 1980s (Brackett et al., Reference Brackett, Bousquet, Boice, Donawick, Evans and Dressel1982), the percentage of embryos that reach blastocyst stage is still much lower than that obtained in vivo (Lequarre et al., Reference Lequarre, Marchandise, Moreau, Massip and Donnay2003). The high rates of embryo mortality might be due to developmental block, a phenomenon described in many species that occurs concomitantly with major genome activation (Meirelles et al., Reference Meirelles, Caetano, Watanabe, Ripamonte, Carambula, Merighe and Garcia2004). Embryonic arrest during major genome activation occurs in cattle during the transition from the 4th to the 5th cell cycle due to the inability to modify the repressive chromatin structure and to activate the transcription of genes that are important for development (Betts & King, Reference Betts and King2001).
Chromatin remodelling is regulated in part by epigenetic modifications, which include post-translational histone modification. The acetylation of histones is related to an increase in gene expression by permitting the access of transcription factors to DNA (Schubeler et al., Reference Schubeler, Macalpine, Scalzo, Wirbelauer, Kooperberg, Leeuwen, Gottschling, O'Neil, Turner, Delrow, Bell and Groudine2004). After fertilization, the embryo genome is methylated and genes are expressed at very low levels (Dean et al., Reference Dean, Santos, Stojkovic, Zakhartchenko, Walter, Wolf and Reik2001). Histone acetylation reaches its peak at the time of embryonic genome activation, which coincides with an overall increase of gene expression levels (Maalouf et al., Reference Maalouf, Alberio and Campbell2008). Histone acetylation is regulated by two main enzymes: histone acetyltransferase, which adds acetyl groups to the histone tail, neutralizing its positive charges and weakening its binding to nucleosomes; and histone deacetylase (HDAC), which removes acetyl groups and causes chromatin compaction and silencing of the DNA segment at that site (Johnstone, Reference Johnstone2002). Experiments that use RNAi-mediated reduction of HDAC confirmed the role of this enzyme in histone acetylation and gene expression in blastomeres (Ma & Schultz, Reference Ma and Schultz2008).
Studying bovine embryos produced in vitro, Ikeda et al. (Reference Ikeda, Tatemizo, Iwamoto, Taniguchi and Hoshino2009) found no effect of the HDAC inhibitor trichostatin A (TSA) administered during in vitro fertilization (IVF) on blastocyst rate, although the drug increased the ratio of inner cell mass cells. However, TSA has been applied successfully to the production of bovine clones in order to increase the efficiency of epigenetic recombination of adult cells in nucleus donor cells (Enright et al., Reference Enright, Kubota, Yang and Tian2003; Wee et al., Reference Wee, Shim, Koo, Chae and Lee2007; Ding et al., Reference Ding, Wang, Zhang, Wang, Guo and Zhang2008), and in embryos immediately after embryo fusion (Ding et al., Reference Ding, Wang, Zhang, Wang, Guo and Zhang2008; Iager et al., Reference Iager, Ragina, Ross, Beyhan, Cunniff, Rodriguez and Cibelli2008). Thus, TSA affects chromatin remodelling by increasing histone acetylation.
The objectives of the present study were to determine an adequate concentration and exposure time of TSA during embryonic genome activation and to evaluate the effects of TSA on the in vitro production of bovine embryos. We tested the hypothesis that TSA would improve blastocyst rates by overcoming chromatin repression.
Material and methods
Supplements
Reagents and culture media were purchased from Sigma Chemical Co. unless otherwise stated.
Preparation and selection of oocytes
Bovine ovaries were collected at a local slaughterhouse and processed within 2 h after slaughter. The ovaries were washed in saline (37°C) and follicles that measured 3 to 8 mm in diameter were aspirated with an 18-gauge needle coupled to a 20-ml syringe. Cumulus–oocyte complexes (COCs) presenting at least three layers of cumulus cells and homogenous cytoplasm were selected under a stereomicroscope. The COCs were washed in HEPES-buffered TCM-199 (Gibco BRL) supplemented with 10% fetal bovine serum (FBS; Cripion, Andradina, Brazil), 16 μg/ml sodium pyruvate, and 83.4 μg/ml amikacin (Instituto Biochimico).
In vitro maturation (IVM)
Groups of 15 COCs were transferred to 100-μl droplets of medium that contained sodium bicarbonate-buffered TCM-199 supplemented with 10% FBS, 1.0 μg/ml follicle-stimulating hormone (FSH) (Follitropin™, Bioniche Animal Health), 50 μg/ml human chorionic gonadotrophin (hCG; Profasi™), 1.0 μg/ml estradiol, 16 μg/ml sodium pyruvate, and 83.4 μg/ml amikacin. The COCs were covered with sterile mineral oil (Dow Corning Co.) and incubated for 24 h at 38.5°C in an atmosphere of 5% CO2 in air under saturated humidity.
In vitro fertilization
After IVM, groups of 25 oocytes were washed twice and transferred to 30-μl droplets of TALP-IVF medium supplemented with 0.6% bovine serum albumin (BSA), 10 μg/ml heparin, 18 μM penicillamine, 10 μM hypotaurine and 1.8 μM epinephrine, and covered with sterile mineral oil. Frozen straws of semen from Nellore bulls were centrifuged on a discontinuous 45/90 Percoll gradient for 5 min at 3600 g. The pellet was resuspended in 2 ml TALP stock medium and again centrifuged for 5 min at 3600 g. After centrifugation, 80 μl of the medium containing the pellet were collected from the bottom of the tube and homogenized in a conical tube. The final suspension was adjusted to a final concentration of approximately 104 live spermatozoa per oocyte. The plates were incubated at 38.5°C for 20 h in an atmosphere of 5% CO2 in air under saturated humidity.
In vitro culture (IVC)
After IVF, presumptive zygotes were denuded of cumulus cells by vigorous pipetting and cultured in synthetic oviductal fluid (SOF) medium supplemented with 2.5% FBS and 5 mg/ml BSA at 38.5°C in an atmosphere of 5% CO2 in air under saturated humidity. Groups of 15 to 20 presumptive zygotes were cultured in 100-μl droplets until the time of treatment with TSA. The cleavage rate, blastocyst development, and blastocyst hatching were evaluated 48 h, 7 days and 9 days after IVF, respectively.
Treatment with trichostatin A
The embryos were washed and transferred to 100-μl droplets of IVC medium supplemented with different concentrations of TSA: 5, 15, 25 and 50 nM, for 12, 24, 48 or 144 h. After the determined exposure times, the embryos were transferred to droplets of TSA-free IVC medium. One half of the medium was changed every 48–72 h.
Assessment of embryo quality by an apoptosis assay (TUNEL) and determination of total blastocyst cell number
Blastocysts were evaluated by the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) assay using the In Situ Cell Death Detection Kit (Fluorescein, Roche Applied Science) as described by Paula-Lopes & Hansen (Reference Paula-Lopes and Hansen2002). Blastocysts were incubated with 0.5% Triton X-100 in phosphate-buffered saline (PBS) for 30 min at room temperature. Next, the embryos were transferred to the final solution containing 10 μl of the enzyme solution (terminal deoxynucleotidyl transferase) and 90 μl of the labelling solution (fluorescein-dUTP) and incubated for 1 h at 38.5°C, followed by incubation with 50 μg/ml RNase A for 1 h at room temperature. The nuclei were stained with 10 μl/ml Hoechst 33342 for 10 min and the blastocysts were washed three times in PBS. The positive control was incubated with 50 IU/ml DNase for 1 h before incubation with the final enzyme/dUTP solution. The negative control was incubated without the enzyme. The number of apoptotic cells and total number of nuclei was determined under a fluorescence microscope (Olympus IX-70) at wavelengths of 330–385 nm (Hoechst 33342) and 420–490 nm (fluorescein).
Statistical analysis
Differences in blastocyst, apoptosis and hatching rates between groups were analysed by the chi-squared (χ2) test using the MINITAB software, Release 14.1 (Minitab Inc., State College, PA). The total cell number was analysed by one-way analysis of variance (ANOVA) and means were compared by the Tukey test using GraphPad Prism 4.0 software (GraphPad Prism, Inc.).
Results
Effect of TSA concentration and time of exposure on blastocyst development
Three replicates corresponding to 1136 oocytes (n = 58–110 per experimental group) were analysed. First, the adequate concentration and exposure time of TSA during IVC of bovine embryos were determined (Fig. 1).
Figure 1 Effects of different concentrations and times of exposure to trichostatin A (TSA) on the development of bovine embryos. In vitro culture medium was supplemented 70 h after in vitro fertilization (IVF) with 5, 15, 25 or 50 nM TSA for 12, 24, 48 or 144 h. Asterisk (*) indicates significant differences compared with the control group and connectors indicate significant differences within the same concentration (p < 0.05, chi-squared test).
No difference was observed in the blastocyst rate between 8-cell embryos exposed to 5 nM TSA for 12, 24, 48 or 144 h and the control group (p > 0.05). For embryos treated with 15 nM TSA, exposure for 12 h did not affect blastocyst rate (p > 0.05). However, blastocyst development was lower than in the control group after 24, 48 and 144 h of treatment with 15 nM TSA (p < 0.05). Treatment with 25 nM TSA for 12 or 24 h reduced the blastocyst rate compared with the control group (p < 0.05). Embryos did not reach the blastocyst stage when exposed to 25 nM TSA for longer periods of time (48 or 144 h) (p < 0.05). The administration of 50 nM TSA resulted in lower blastocyst development compared with the control group when the embryos were exposed for 12 h (p < 0.05). Embryos did not reach the blastocyst stage when 50 nM TSA was administered for longer periods of time (24, 48 and 144 h) (p < 0.05).
In a second experiment, we carefully investigated the effects of adequate TSA treatment on embryonic development. For this purpose, 1732 cleaved embryos obtained in nine replicates (n = 371–555 cleaved embryos per experimental group) were exposed to 5 nM for 48 h, 15 nM for 48 h, and 5 nM for 144 h. All of the TSA concentrations tested promoted a decrease in blastocyst rate (Table 1).
Table 1 Effects of supplementation of in vitro culture medium with trichostatin A on the development of bovine embryos (Experiment 2)
Trichostatin A (TSA) was added to the in vitro culture medium 70 h post-fertilization. The percentage of blastocysts refers to the total number of cleaved embryos.
a, b, cMeans followed by the same letter did not differ significantly (p < 0.05, chi-square test). Data from nine replicates.
n = number of structures.
Effects of TSA on blastocyst hatching
Five replicates corresponding to 418 blastocysts (n = 68–159 per experimental group) were analyzed. Treatment with 5 nM TSA for 48 h had no effect on the percentage of blastocyst hatching (p < 0.05) (Table 2). However, TSA promoted a decrease in blastocyst hatching at concentrations of 15 nM applied for 48 h and of 5 nM applied for 144 h (p < 0.05).
Table 2 Effects of supplementation of in vitro culture medium with trichostatin A on blastocyst hatching of bovine embryos
Trichostatin A (TSA) was added to the in vitro culture medium 70 h post-fertilization.
a, b, cMeans followed by the same letter did not differ significantly (p < 0.05, chi-squared test). Data from five replicates.
n = number of structures.
Effects of TSA on total cell number and apoptosis rates of bovine blastocysts
In this experiment, four replicates corresponding to 91 blastocysts (n = 16–27 per experimental group) were analysed. No difference was observed in apoptosis rates or total cell number between the four experimental groups (p > 0.05) (Table 3). Therefore, harmful effects on cell cycle or apoptosis were not observed in the experimental groups studied.
Table 3 Effects of supplementation of in vitro culture medium with trichostatin A on apoptosis rate and total cell number of bovine blastocysts
Trichostatin A (TSA) was added to the in vitro culture medium 70 h post-fertilization. Apoptosis rate and total cell number are reported as the mean ± standard error.
A, aMeans followed by the same letter did not differ significantly (p < 0.05, one-way analysis of variance (ANOVA) and Tukey post test). Data from four replicates.
n = number of structures.
Discussion
The present study provides data regarding the effect of TSA supplementation on bovine preimplantation development. The results showed that even at low concentrations TSA decreased the blastocyst rate, although no harmful effects on embryo quality were observed.
The first cycle of DNA replication after embryonic genome activation is critical for the maximum expression of endogenous genes (Aoki et al., Reference Aoki, Worrad and Schultz1997). Thus, the time of TSA supplementation chosen in the present experiment was 70 h post-IVF, when most embryos were in the 8-cell stage. At this time, HDAC inhibition and the consequent increase in gene expression may contribute to overcome chromatin repression.
The results of the first experiment showed that higher concentrations of TSA can be applied for 12 h. However, our aim was to use the drug for longer periods of time when most embryos are in the fourth and fifth cell cycle and to include the remaining cycles of preimplantation development. For this purpose, administration of 5 nM TSA for 48 h and 144 h and 15 nM for 48 h was chosen for Experiment 2.
In a previous study, we demonstrated that male and female embryos respond in a different manner to TSA treatment (Oliveira et al., Reference Oliveira, Saraiva, Souza, Tetzner, Lima and Garcia2010). Therefore, TSA was administered to in vitro produced embryos fertilized with non-sexed sperm, which produces both male and female embryos in the same drop. The objective was to determine a concentration that would not negatively affect blastocyst development, blastocyst hatching, total cell number or apoptosis.
In conventional systems, IVC increases the proportion of male embryos, which develop faster (Avery et al., Reference Avery, Jorgensen, Madison and Greve1992) and reach the blastocyst stage more frequently (Xu et al., Reference Xu, Yadav, King and Betteridge1992). It is possible that the negative effect on blastocyst rate observed was due to an altered sex proportion of embryos that developed in the presence of TSA, as male embryos seem to be more sensitive to the negative effects of TSA (Oliveira et al., Reference Oliveira, Saraiva, Souza, Tetzner, Lima and Garcia2010).
Studies in mice have demonstrated that HDAC plays a role in preimplantation embryonic development by regulating the access of chromatin to transcription factors and consequently decreases gene expression (Ma and Schultz, Reference Ma and Schultz2008). HDAC inhibition by trapoxin promotes histone hyperacetylation and increases gene transcription in mouse embryos (Aoki et al., Reference Aoki, Worrad and Schultz1997). In addition, other HDAC inhibitors have been shown to act as reprogramming agents in cloned bovine embryos (Enright et al., Reference Enright, Kubota, Yang and Tian2003; Wee et al., Reference Wee, Shim, Koo, Chae and Lee2007; Ding et al., Reference Ding, Wang, Zhang, Wang, Guo and Zhang2008; Iager et al., Reference Iager, Ragina, Ross, Beyhan, Cunniff, Rodriguez and Cibelli2008).
Unfortunately, HDAC inhibition does not target specific mechanisms that would result in the increased expression of specific genes. Thus, both beneficial and harmful genes are stimulated and their increased expression activates different pathways that improve or worsen embryonic development. The ideal concentration of TSA in IVC should increase gene expression in such a way that the balance between harmful and beneficial genes is shifted in favour of the latter. This shift was not achieved with the TSA concentrations tested in the present study (5–50 nM). Higher concentrations blocked blastocyst development completely when applied for 24 h (50 nM) or 48 h (25 nM).
In conclusion, the most suitable concentration of TSA and period of administration are 5 nM and 48 h, although there was no beneficial effect on the parameters studied. Further studies are needed to investigate embryo implantation and birth, as well as the gene expression profile in TSA treated embryos, as they present histone hyperacetylation and are as viable as control embryos.
Acknowledgements
The authors thank Roberta Vantini for technical assistance in the IVF laboratory. This study was supported by the State of Sao Paulo Research Foundation (FAPESP), Brazil.
